We are live on ! Find out more
CCCC icon

C4 Therapeutics
CCCC

114 hedge funds and large institutions have $353M invested in C4 Therapeutics in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 31 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

614% more call options, than puts

Call options by funds: $257K | Put options by funds: $36K

52% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 31

19% more capital invested

Capital invested by funds: $298M → $353M (+$55.1M)

1.5% more ownership

Funds ownership: 80.81% → 82.31% (+1.5%)

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

1% more funds holding

Funds holding: 113 → 114 (+1)

Holders
114
Holders Change
+1
Holders Change %
+0.88%
% of All Funds
1.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
47
Reduced
31
Closed
16
Calls
$257K
Puts
$36K
Net Calls
+$221K
Net Calls Change
-$2.03M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$12.9M
2
SCM
Soleus Capital Management
Connecticut
+$12M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$8.18M
4
Goldman Sachs
Goldman Sachs
New York
+$3M
5
WA
Wasatch Advisors
Utah
+$2.78M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$14.7M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$7.79M
3
SFM
Sphera Funds Management
Israel
-$5.32M
4
Millennium Management
Millennium Management
New York
-$3.21M
5
RI
RTW Investments
New York
-$2.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
Mirae Asset Global Investments
76
Mirae Asset Global Investments
South Korea
$154K -$48.2K -4,641 -21%
Deutsche Bank
77
Deutsche Bank
Germany
$153K -$9.75K -939 -5%
VOYA Investment Management
78
VOYA Investment Management
Georgia
$144K +$13.5K +1,297 +9%
Invesco
79
Invesco
Georgia
$142K +$24.9K +2,401 +17%
CAPTRUST Financial Advisors
80
CAPTRUST Financial Advisors
North Carolina
$130K – – –
BMSSC
81
B. Metzler seel. Sohn & Co
Germany
$129K +$153K +14,700 New
Commonwealth Equity Services
82
Commonwealth Equity Services
Massachusetts
$121K -$8.48K -817 -6%
RC
83
RegentAtlantic Capital
New Jersey
$111K +$13.7K +1,315 +12%
XT
84
XTX Topco
Cayman Islands
$110K +$130K +12,549 New
Legal & General Group
85
Legal & General Group
United Kingdom
$109K +$10.6K +1,017 +9%
Rockefeller Capital Management
86
Rockefeller Capital Management
New York
$104K – – –
SEI Investments
87
SEI Investments
Pennsylvania
$102K +$120K +11,601 New
Teacher Retirement System of Texas
88
Teacher Retirement System of Texas
Texas
$98K +$116K +11,185 New
EAM
89
Erste Asset Management
Austria
$91.4K – – –
TRCT
90
Tower Research Capital (TRC)
New York
$89K +$75.5K +7,268 +257%
SW
91
SVB Wealth
Massachusetts
$88K +$104K +10,007 New
Ensign Peak Advisors
92
Ensign Peak Advisors
Utah
$63K +$48.5K +4,670 +182%
Wells Fargo
93
Wells Fargo
California
$54K +$59.2K +5,707 +1,137%
SO
94
STRS Ohio
Ohio
$49K – – –
AB
95
Amalgamated Bank
New York
$45K – – –
Lazard Asset Management
96
Lazard Asset Management
New York
$41K +$48.6K +4,685 New
Nisa Investment Advisors
97
Nisa Investment Advisors
Missouri
$30K – – –
Zurich Cantonal Bank
98
Zurich Cantonal Bank
Switzerland
$30K – – –
Amundi
99
Amundi
France
$27K +$31.4K +3,023 New
AIP
100
Ameritas Investment Partners
Nebraska
$25K – – –
2 3
4
5 6

CCCC Hedge Fund Activity: Q3 2022 in Review

114 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in C4 Therapeutics (CCCC) for Q3 2022, worth a combined $353M — up 19% from $298M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CCCC positions and 16 closed out — a net gain of 1 holder — while 47 added to existing stakes and 31 trimmed.

The largest buyer was State Street, adding an estimated $12.9M. The largest seller was T. Rowe Price Associates, cutting an estimated $14.7M.

  • 114 institutional investors held C4 Therapeutics (CCCC) as of Q3 2022, up from 113 in Q2 2022.
  • Funds reported $353M of C4 Therapeutics stock for Q3 2022, up 19% quarter-over-quarter.
  • 17 funds opened new C4 Therapeutics positions in Q3 2022 and 16 closed out, a net change of +1 holder.
  • The largest C4 Therapeutics buyer in Q3 2022 was State Street, an estimated $12.9M added.
  • The largest C4 Therapeutics seller in Q3 2022 was T. Rowe Price Associates, an estimated $14.7M sold.

Based on aggregated 13F filings for Q3 2022.